No Data
No Data
Sector Update: Health Care Stocks Retreat Friday Afternoon
Small-Cap OS Therapies Inks Commercial Manufacture Agreements For Lead Cancer Drug For Rare Type Of Bone Cancer
OS Therapies Says It Signed Manufacturing Deal for Lead Candidate OST-HER2
Wall Street Set to Open Slightly Lower Friday as Retail Sales Slump More Than Expected
OS Therapies Shares Are Trading Higher After the Company Announced Agreements for the Commercial Manufacture of OST-HER2.
OS Therapies Initiates Commercial-ready Manufacturing of OST-HER2 to Support Anticipated Biologics Licensing Authorization (BLA) Filing
TheOracleOfBroMaha : Nice. Do you think it’s wise to enter now or do you think it will drop it all or is it a wait and see.? I assume you’re already in it to a degree I don’t own any. What would you be thinking if you were me?
TheOracleOfBroMaha : thank you in advance and I know it’s not advice, but I appreciate sharing
ZanX OP TheOracleOfBroMaha : I'll suggest to wait, look for potential pullback before the breakout.
TheOracleOfBroMaha : thank you, my friend